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ABSTRACT
Introduction: Apert syndrome is a rare type of syndromic craniosynostosis. Patients have an explicit
phenotype with craniofacial dysmorphologies and severe symmetrical syndactyly of the hands and feet.
This review includes background information about the syndrome and several aspects of the treatment.
Areas covered: The cause of Apert syndrome is found in unique mutations in the Fibroblast Growth
Factors Receptor (FGFR) 2 gene in 99%. It results in cranial suture fusion, craniofacial dysmorphologies
and severe symmetrical syndactyly of the hands and feet. Patients with Apert syndrome are at risk for
mental retardation, mobility impairment and intracranial hypertension (ICHT). This is the result of a
complex interaction between (1) abnormal skull growth, (2) ventriculomegaly, (3) venous outflow
obstruction and (4) obstructive sleep apnea (OSA). Mental retardation is mainly determined by the
FGFR2 mutation and treatment is directed at protecting the intrinsic potential of neurocognition.
Expert Opinion: To prevent ICHT, we prefer an occipital expansion in the first year of life. Screening on
ICHT and its underlying causes is necessary at least until the age of ten by means of skull circumference
measurements, fundoscopy, optical coherence tomography, MRI and polysomnography. Multicentre
studies on long-term outcome are required to validate the rationale of different clinical protocols.
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1. Introduction
Apert syndrome is a rare type of syndromic craniosynostosis.
Children have an explicit phenotype with craniofacial dys-
morphologies (Figure 1) and severe symmetrical syndactyly
of the hands and feet (Figure 2). These features of acrocepha-
losyndactyly were first observed and published by the French
pediatrician Eugène Charles Apert in 1906 [1,2]. In total, 21%
of all cases of craniosynostosis is syndromic, and out of all
syndromic cases 4.5% is represented by Apert syndrome [3,4].
The prevalence is estimated to be 1 in 65.000–75.000 live
births [5,6]. The highest prevalence is found in Asia, where it
is 1 in 45.000 live births. It occurs equally in boys and girls.
Several pioneers have been treating children with Apert
syndrome for over half a century [7]. We will discuss where
their experiences and research has brought us so far.
2. Genetics
Most cases of Apert syndrome are sporadic, although autosomal
dominant inheritance could occur in case of natural propagation
of an affected individual. The cause of Apert syndrome is found in
unique mutations (Ser252Trp (nucleotide change c.755C>G) and
Pro253Arg (nucleotide change c.758C>G)) in the Fibroblast
Growth Factors Receptor (FGFR) 2 gene in 99% [8]. Besides these
mutations, a deletion and insertion in exon IIIc of FGFR2 have been
reported as rare causes of Apert syndrome [9]. All these genetic
changes have a gain-of-function effect. It leads to abnormal
expression of the altered FGFR2 splice form in the mesoderm-
derived mesenchyme of the corona suture [10]. This induces an
accelerated proliferation and differentiation of the mesenchymal
cells resulting in osteogenesis. Consequently, the coronal suture
fails in its function of facilitating skull growth. Instead, synostosis of
the frontal bone to the parietal bone occurs [11,12].
Besides affecting the cranial sutures, the FGFR2 changes are
also likely to directly affect the brain, as has been demon-
strated in a mouse model. In mice with the Ser252Trp muta-
tion, there is an increase in brain size at post-natal day 0,
suggesting that this is a primary rather than a secondary
anomaly. Other brain anomalies include cerebral asymmetry
and corpus callosum dysmorphology [13]. Regarding the skull
base, the rostral regions are affected by primary shape
changes. The basio-occipital and parietal regions however
are subject to secondary shape changes [11].
Interestingly, there is a positive effect of paternal age on
the prevalence of Apert syndrome [14]. New mutations, which
are dependent on replication, tend to occur more often with
advanced age of the father. This is due to positive selection of
mutant spermatogonial progenitor cells in the paternal germ
line, resulting in high levels of FGFR2 mutant sperm [15].
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3. Diagnosis
Apert syndrome is primarily a clinical diagnosis, based on the
phenotype of head shape (Figure 1), hands, and feet
(Figure 2). A newborn is presented most commonly with
brachycephaly due to bicoronal synostosis, often
accompanied by an enlargement of the anterior fontanel up
to the nasal bones. Other features include hypertelorism,
exorbitism, midfacial hypoplasia and – to a lesser extent –
mandibular hypoplasia.
It is recommended to first perform a targeted analysis to
confirm the pathogenic variants p.Ser252Trp and p.
Pro253Arg on the FGFR2 gene. If these results are negative,
one could perform a sequence analysis to detect less com-
mon pathogenic variants such as partial gene deletion or
insertion [9].
With the improved accuracy of regular antenatal ultrasonic
studies, the phenotypic features may be discovered before
birth. Retrospective analyses show that craniosynostosis may
be diagnosed prenatally in the second trimester due to
enlarged ventricles and syndactyly of the extremities or later
when the craniofacial deformities become more pronounced.
Recent studies show an improvement in antenatal diagnosis
using 2D and 3D ultrasound and even MRI [16]. This is an
important improvement since early awareness contributes to
thorough counseling of the expectant parents. Additionally,
delivery in a specialized hospital is urgently recommended
because of the increased risk of perinatal complications
which consist of traumatic hematomas due to cephalo-pelvic
disproportion and an increased risk of unplanned cesarean
section [17]. Moreover, severe breathing abnormalities may
be present in Apert syndrome and the hospital should be
capable of urgent intubation of the child if necessary.
4. Morbidity
The problems that patients with Apert syndrome face can be
divided into the craniofacial anomalies, the problems asso-
ciated with acrosyndactyly and additional congenital
anomalies.
4.1. Craniofacial anomalies
The exact shape of the abnormal skull depends on which
particular suture is involved. Most often both coronal sutures
are closed, the anterior fontanel is enlarged and frontal bos-
sing is obvious. However, also other sutures may be involved
resulting in an atypical presentation including metopic suture
synostosis [18]. Around the age of one, the biggest concern
becomes intracranial hypertension (ICHT). Beforehand, in most
of the cases, the anterior fontanel is wide which prevents ICHT
until ossification occurs. In initially nonoperated cohorts, 83%
of all patients with Apert syndrome develop evident signs of
raised intracranial pressure early in life, on an average age of
18 months [19]. Of these patients, 35% developed a second
episode of raised intracranial pressure on average 3 years after
the initial episode. In a cohort of patients of which 95% was
operated primarily (so before ICHT developed), 14% also
developed ICHT during follow up [20]. The Australian
Craniofacial Unit has reported that only two of 28 adult
patients with Apert syndrome had required shunting after
initial cranial vault remodeling (mainly frontal-occipital expan-
sion) [21]. A long-term follow-up on nine patients in Los
Angeles showed that all but one needed a Monobloc advance-
ment after initial strip craniectomy or frontal-occipitalFigure 2. Acrosyndactyly and symphalangism.
Figure 1. Brachycephaly, exorbitism and midfacial hypoplasia.
Article highlights
● Apert syndrome is a rare syndrome with craniofacial dysmorphologies
and severe symmetrical syndactylies.
● Multidisciplinary treatment in a specialised center is required to
achieve the best mental outcome.
● Patients are at risk for intracranial hypertension.
● To prevent this, we prefer an occipital expansion in the first year of
life.
● Screening for intracranial hypertension is strongly recommended at
least until the age of ten.
This box summarizes key points contained in the article.
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expansion, but it is unknown if they had a (recurrent) period of
ICHT [22].
ICHT is the result of a complex interaction between (1)
abnormal skull growth, (2) ventriculomegaly, (3) venous out-
flow obstruction, and (4) obstructive sleep apnea (OSA).
(1) Deficient skull growth may result in ICHT [23]. It is
detected through a fall-off in occipito-frontal head cir-
cumference growth, which is closely related to the
intracranial volume [24].
(2) Children with Apert syndrome have larger ventricles
[25]. The brain volume itself is normal. We observe
exaggerated expansion of the ventricles at the site of
the most expansive compensatory growth, sometimes
accompanied by enlarged subarachnoid spaces in these
areas. It usually remains stable over time [25]. The effect
of ventriculomegaly on the brain is unknown. The cause
of ventriculomegaly is also unclear. It may reflect a
primary brain abnormality, overproduction of CSF,
reduced absorption, or obstructed outflow of CSF [26].
Although compensatory skull growth results in a larger
than normal skull volume, the cerebrum profits only in
part from this skull volume due to ventriculomegaly.
There might even be a disadvantage to this enlarged
volume by the consequent elongation of the white
fibers.
(3) Venous outflow obstruction manifests as abnormal
venous collaterals and dilated emissary veins, particularly
at the occipital area [27]. This appears to be a congenital
abnormality of the venous system, and not so much a
compensating reaction to ICHT. It is likely that venous
hypertension plays an important role in the development
of ICHT [28,29].
(4) There is a high prevalence of 70% of OSA in children
with Apert syndrome, which is the result of a multi-
level upper airway obstruction [30,31]. The spectrum
runs from upper airway resistance, without real apneas
up to severe obstructed breathing. OSA may result in
hypercapnia and subsequent vasodilatation of the cer-
ebral vasculature which contributes to ICHT [32]. As a
result of relaxation of the pharyngeal musculature,
OSA occurs mainly in rapid eye movement sleep,
when the intracranial pressure already rises due to
increased blood flow [33]. OSA and intracranial pres-
sure are interrelated and treatment of ICHT should go
hand in hand.
Sleep apnea is preferably measured using polysomnography
(PSG). This is a multi-parametric test over night that captures
electro-encephalography, heart rate, oxygen saturation,
respiration movements, and intravenous CO2 examination.
PSG studies have shown a higher respiratory effort-related
arousal index, lower sleep efficiency, and less rapid eye
movement sleep in patients with syndromic craniosynostosis
with moderate or severe OSA [33]. For follow-up, ambulant
polygraphy may be considered [34]. Extreme deterioration of
OSA for an individual patient is uncommon, which implies
that the first PSG produces a good predictive value for
expected severity of OSA during the following years.
Spontaneous improvement of OSA is unlikely in Apert syn-
drome [31].
Snoring, persistent upper airway resistance, and mild OSA
are not associated to ICHT, but may require treatment if
patients are symptomatic, such as tiredness during the day
[35]. Central sleep apnea is commonly found in the sleep
studies during the first year of life, but appears self-limiting
with advancing age [30].
Prolonged ICHT may structurally affect the optic nerve and
the brain itself and therefore further visual impairment and
neurocognitive delay are feared. Moreover, ICHT may lead to a
herniation of the hindbrain. If this herniation is more than
5 mm through the foramen magnum, it is called a Chiari I
malformation. Data on the prevalence of the Chiari I malfor-
mation among patients with Apert syndrome are variable,
differing from 2% to 29% [25,36,37].
4.2. Visual impairment
In addition to the effect of ICHT on the optic nerve, children
with Apert can present with severe exorbitism caused by mid-
face hypoplasia. The overexposed cornea is vulnerable due to
insufficient eyelid closure, which may cause conjunctivitis and
keratitis. Also, amblyopia and visual impairment are more
common in patients with the FGFR2 Ser252Trp mutation
[38,39]. Strabismus is present in as much as 93% of all patients
and a refractive error was found in 76% [20].
4.3. Central nervous system malformations
Agenesis of the corpus callosum (12–50%), anomalies of the
septum pellucidum (24% PMID) and hydrocephalus (33.3%)
may be present [37,40].
4.4. Mental retardation
Most patients exhibit mental retardation and behavioral dis-
abilities. The mean Full Scale IQ score in patients with Apert
syndrome was 76.7 ± 13.3 in our cohort. These data are
comparable to those in other cohorts in which they vary
from 62.0 to 93.8 (range 10–115). Generally, patients with
syndromic craniosynostosis have more internalizing, social
and attention problems, but not more externalizing problems,
as measured by the Child Behavior Checklist. Also, ADHD-any
type and ADHD-hyperactive-impulsive type is more common
in children who have syndromic craniosynostosis [40].
Generally, for craniosynostosis, there is increasing evidence
that the functional and mental outcome is better after early
cranial vault expansion. Specifically, for Apert syndrome, it
seems that there is a higher risk of mental retardation, regard-
less of surgery [41], which is related to the FGFR2 mutation.
Three main associated factors for a better mental outcome are
the combination of cranial surgery before the age of one, the
absence of brain malformations, and high quality psychosocial
environment. A posterior surgical expansion usually with dis-
traction is routinely recommended before the age of one.
Long-standing ICHT and sleep apnea should be avoided to
preserve the cognitive capacities as much as possible. Finally,
there is a correlation between developmental outcome and
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treatment at an expertise center from birth on, which is there-
fore highly recommended [37].
4.5. Acrosyndactyly
Patients with Apert syndrome have acrosyndactyly and sym-
phalangism, involving fingers and toes in mostly a symmetri-
cal manner. The patients with the Pro253Arg mutation are
often affected by a more severe syndactyly [42]. The hand
deformity is classified into three types (Table 1). As a result
of the syndactyly, the thumb is short and radially deviated.
Synonychia with paronychia may be present, depending on
the type. Additionally, patients have decreased mobility of the
shoulder and elbow joint which becomes worse with increas-
ing age. Hips and knees may also be involved, as well as the
ankle joints and feet, resulting in an often-overlooked severe
functional impairment.
4.6. Other
– Cleft palate; of which there is some evidence that it
occurs more often in the patients with a Ser252Trp
mutation. A retrospective cohort showed an incidence
of palatal abnormalities of 50% [43].
– Hearing loss is present in 72–80% of patients with Apert
syndrome [20,44]. 11% needed a hearing aid [20]. In the
majority of patients, it concerns a conductive hearing
loss. This is explained by the effect of FGFR2 on the
development and function of inner ear and auditory
sensory epithelium [44].
– Cervical anomalies were present in 50.8 % in a retro-
spective cohort. These included fusions of posterior ele-
ments of C5/C6 in the majority of patients, C3/4 or
multilevel. Other abnormalities were C1 spina bifida
occulta and atlanto-axial subluxation [45].
– Heart diseases include septal defects, dextrocardia, and
aorta anomalies including tetralogy of Fallot.
– Skin anomalies consist of hyperhidrosis and acneiform
lesions. These may become so severe during puberty that
treatment by a dermatologist is required and it may have a
huge effect on psychosocial well-being of the patient.
– Urogenital abnormalities vary between kidney, bladder,
and vaginal deformities.
– The presence of diaphragmatic hernia and omphalocele
has also been reported on [46,47].
5. Treatment
The treatment of Apert syndrome may vary per unit and child.
We present the treatment protocol that is followed in the
Dutch Craniofacial Center in Rotterdam.
5.1. Pre- and early postnatal care
In case of antenatal detection of Apert syndrome a consulta-
tion at a craniofacial unit to counsel the expectant parents is
recommended. After birth, it is important to immediately
assess the presence of obstructive breathing and desatura-
tions. In case of OSA, the airway patency can improve with
prone or lateral positioning. If closure of the eyelids is incom-
plete, prescription of lubricating eye ointment may be neces-
sary. A pediatrician should be consulted to analyze the
presence of other anomalies.
5.2. Craniofacial surgery
Cranial vault expansion addresses both craniocerebral dispro-
portion as well as venous hypertension [23].
(1) It is our protocol to start with a posterior vault remo-
deling within the first year of life. The increase in
volume is higher after a posterior vault expansion com-
pared to a fronto-orbital advancement [48], and there-
fore the preferred primary approach, either with the use
of springs or distractors. This also leaves the anterior
part of the skull untouched for future anterior cranial or
facial surgery. Moreover, the flattening of the occiput,
commonly present due to hypotonia of the child, is
addressed at the same time.
(2) If a child has recurrent eyeball luxations, a monobloc
advancement with internal distraction and a transfacial
pin is indicated rather than a posterior vault expansion.
Sometimes, a tarsoraphy is the only temporarily solution to
protect the eyeball when waiting for midface
advancement.
(3) If a child has severe OSA, we prefer a tracheal cannula
temporarily since a monobloc advancement with internal
distraction is safer at the age of 2 or 3 years old. It should
be excluded that the problem is based at the level of the
tongue base. If so, a monobloc will not resolve OSA and
mandibular distraction may be necessary for which we
also prefer an age of at least 2–3 years old.
(4) Stable ventriculomegaly does not require shunting.
Venous outflow hypertension associated with an
absence of true hydrocephalus is a contraindication
for neurosurgical shunting.
(5) Hindbrain herniation is not as frequent as in Crouzon
syndrome and often not symptomatic. However,
Table 1. Acrosyndactyly of the hand in Apert syndrome.
Thumb Digit 2, 3, 4 Digit 5
Type I Brachyclinodactyly
Incomplete 1st-
web syndactyly
Symphalangism
Complex
syndactyly
Simple (incomplete)
syndactyly of 4th web or
separate digit
MC 4–5 synostosis
possible
Type II Brachyclinodactyly
Simple
(incomplete)
syndactyly
Symphalangism
Complex
syndactyly
Complete syndactyly
Duplication P3 possible
MC 4–5 synostosis
possible
Type III Brachyclinodactyly
Complex
syndactyly
Paronychial
infections
Skin
maceration
Symphalangism
Complex
syndactyly
Paronychial
infections
Skin
maceration
Complete syndactyly
Duplication P3 possible
MC 4–5 synostosis
possible
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hindbrain herniation may need shunting or suboccipital
decompression in case of progressive neurological
signs or radiological progression, especially the devel-
opment of a syrinx.
5.3. OSA
Treatment of OSA in patients with Apert syndrome should be
adapted to the outcome of a sleep study and the level of
obstruction which is analyzed using upper airway endoscopy
[30]. It may vary from tracheostomy, treatment of choanal
atresia, nasal corticosteroids, adenotonsillectomy, noninvasive
ventilation, palatal split, and midface advancement [21,31].
The disturbed sleep architecture in patients with Apert syn-
drome was shown to normalize after monobloc surgery [33]. If
a cleft palate is present, timing of surgical closure should be
critically considered in case of OSA.
5.4. Hand surgery
The aim is to reconstruct a five-fingered hand, although this may
be difficult in case of a type III complex syndactyly [49]. Surgery is
staged. The early phases include releasing and reconstructing the
thumbwith desyndactylization of one ormorewebs. A free thumb
is essential to facilitate pinch and large object grasp. This improves
neurocognitive development [50,51] and is therefore performed
within the first half year of life. The goal is to achieve a pulp-to-pulp
pinch to the index finger or little finger [43]. In addition to the
reconstruction of the hand, an increase in surgery of the feet is
performed in the last decade at our department, with promising
results. Recently, the hip, knee, shoulder, and elbowcomplaints are
more often recognized by specialists and treated if necessary.
Inclusion of a rehabilitation specialist within the team is essential.
Operations of the hand and feet have to be carefully
planned, starting with first stages in the first year of life,
depending on the type of hand difference, and the planning
of craniofacial-related reconstructions.
5.5. Neurocognition
Screening by a pediatric psychologist is recommended from
the age of 3 years old onwards to screen for associated
psychopathology. Moreover, the support from a social worker
is required to support the parents in how to cope with raising
a child with Apert syndrome.
5.6. Follow up
Recurrence of ICHT should be followed up by means of
repeated skull circumference measurements, fundoscopy,
optical coherence tomography (OCT), MRI, and PSG. If there
is a suspicion of a recurrent episode of ICHT, consider invasive
ICP monitoring. If ICHT is confirmed, the cause should be
analyzed and treated. This may be an insufficient intracranial
volume or OSA. Patients could undergo a redo of the occipital
expansion or fronto-orbital advancement, which depends on
the shape of the skull. Preferably, MRI and CT angiography are
then required for surgical planning.
6. Conclusion
Children with Apert syndrome are prone to develop ICHT, func-
tional impairment and mental retardation, which is partially
caused by the FGFR2 mutation. Early release of the thumb is
beneficial for childhood development. Mental outcome seems to
improve if patients are treated early and preferably by means of
occipital expansion. Abnormal skull growth, ventriculomegaly,
venous outflow obstruction, and OSA should be monitored clo-
sely. Centralizing care in an expert center is of utmost importance
for the benefit of the child. Treatment should be individualized
but derived from an evidence-based protocol for which multi-
center studies of different clinical protocols are required. This
includes an analysis of ICHT prevalence, neurocognition, visual
outcome, and presence of Chiari with or without syrinx after
long-term follow up. By gaining these new insights, treatment
can be customized as much as possible to prevent additional
harm to a child with Apert syndrome. Our aim is to offer them the
best functional and cognitive outcome and achieve an appear-
ance which resembles ‘normal’ as much as possible.
7. Expert opinion
Our expert opinion is based on the literature that we discussed
above and over 40 years of experience in the treatment of
patients with Apert syndrome. Traditionally, the preferred initial
cranioplasty was a fronto-orbital advancement. Since 2005, we
prefer occipital expansion and ever since we perform an occipital
expansion first, the incidence of ICHT and Chiari I malformation
during follow up has decreased [48,52].
Worldwide, there is a minority who chooses to wait and see if
secondary symptoms of ICHT arise instead of performing a cra-
nioplasty regularly [19]. Follow up is performed by means of
fundoscopy, optical coherence tomography, or visual evokes
potentials scans every few months to study the optic nerve
[53]. Opponents of this approach claim that optic nerve abnorm-
alities are a late phenomenon of ICHT, the current ophthalmolo-
gic investigations are insufficiently reliable and that mental
outcome may be better in the patients operated on early [54].
Some clinics routinely perform a fronto-orbital advancement a
year after the occipital expansion. They will later perform a LeFort
III osteotomy with distraction to address themidface. We prefer to
wait to perform a monobloc advancement, as this can be done
with internal distractors instead of an external frame and because
it preserves the frontonasal angle, while a Le Fort III elongates the
nose. If there is no severe exorbitism, OSA or ICHT, we wait until
the age of seven. A facial bipartition is preferred if hypertelorism
needs to be addressed simultaneously. This procedure requires
the use of an external frame for the initial distraction, while the
consolidation period can bemanaged with the internal distractors
only. An external framemight be contraindicated in Apert patients
with significant behavioral issues. The age for these midface pro-
cedures varies among different leading centers from 2 to 10 years
old, but could also be postponed until adulthood. The potential
downside of midface advancement is velopharyngeal insuffi-
ciency. These odds appear to be higher if there is, or has been, a
cleft palate. Recognition, speech analyses, and therapy is then
recommended. Sometimes it is indicated to surgically widen the
narrow maxilla.
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In our experience, additional orthognathic surgery is indicated
at the age of 18, when skeletal maturity is reached, to correct open
bite and remaining skeletal dysbalance. This is preceded by ortho-
dontic treatment. Other procedures include repositioning of the
zygoma and nasal septum correction.
In our expertise center there is a narrow collaboration of
plastic surgeons, neurosurgeons, maxillofacial surgeons, specia-
lized intensive care pediatricians, ENT surgeons, ophthalmolo-
gists, orthodontics, speech therapists, social workers, medical
psychologists, and a dedicated nurse practitioner to facilitate
optimal care. There is a craniofacial outpatient team meeting at
the age of 4, 6, 9, 12, 15, and 18 years old. The current work up
and follow up of our children with Apert syndrome is listed in
Table 2. We have an ongoing prospective study that enables us
to continuously update our treatment protocol with the latest
scientific conclusions to provide the best care possible.
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